Eight Sleep Continues Expansion Into Europe With Pod Pro Cover Now Available for Purchase in Belgium, France, Germany, Italy, Netherlands and Spain
Eight Sleep, the world's first sleep fitness company, today announced that customers based in Belgium, France, Germany, Italy, Netherlands and Spain can now purchase the brand’s best-selling Pod Pro Cover, exclusively at eightsleep.com. Available sizes will be EU Double, EU Large Double and EU Super King. The Pod Pro Cover uses PerfectFitTM design to fit any mattress of up to 40cm (16 inches) in height so users can enjoy Eight Sleep’s proprietary sleep improving technology while continuing to use their current mattress. Today’s announcement immediately follows Eight Sleep’s expansion to the UK which began last month, delivering on the company’s plan to extend distribution to international markets following their Series C round of $86M.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211117005295/en/
Eight Sleep Continues Expansion into Europe with Pod Pro Cover Now Available for Purchase in Belgium, France, Germany, Italy, Netherlands and Spain (Photo: Business Wire)
The Pod Pro Cover helps people sleep better and ultimately, live better, longer, happier lives by leveraging innovative technology to create a personalized microclimate in bed. Using health-grade sensors and creating individual AI models, the Pod Pro Cover adapts the sleeping temperature by responding to each user’s sleep patterns, temperature preferences, environment values, and feedback history. This data-driven approach guides the user towards sleep optimization, and case studies have shown that Eight Sleep products help users to fall asleep up to 40% faster, get up to 20% more deep sleep, experience 30% fewer mid-night wake ups, and up to 30% fewer tosses and turns.
Currently more than 100 pro athletes rely on the Eight Sleep Pod technology to power their recovery, including current and former Olympians Matthew Dellavedova (2020 Bronze Medalist, Basketball), Daryl Homer (2020, and 2016 Silver Medalist, Fencing), Jane Campbell (2020 Bronze Medalist, Soccer), Apolo Ohno (Two-Time Gold Medalist, Speed Skating), Justin Medeiros (2021 Crossfit Games and 2021 Rogue Invitational Winner) and Daniel Sturridge (English Soccer Player).
The Pod Pro Cover is available for purchase and delivery in select Europe countries as of today with prices starting at $1,695 USD. At checkout, prices are reflected in USD, but EU-based customers will be charged in local currency based on the exchange rate at that moment. There are no additional costs for shipping, duties or returns. Eight Sleep maintains its 30-day free returns policy, as well as a 2-year limited warranty for any Pod Pro Cover purchased directly from the company.
“Our recent expansion to the UK was just the start of scaling our business globally and we’re excited to announce six more countries in Europe that now have access to our advanced tech-based products improving overall health,” said Matteo Franceschetti, Co-founder and CEO of Eight Sleep. “With the goal of becoming accessible to all people, continued growth is a focal point right now. We are helping people everywhere achieve optimal health and that requires availability. This an exciting step for more users throughout Europe to join existing customers as devoted fans of Eight Sleep products.”
Eight Sleep: Creating the Sleep Fitness Movement
Eight Sleep has revolutionized the archaic sleep category by leading the way in the sleep fitness movement. Eight Sleep recently announced an exclusive collaboration with leading global fitness brand Barry’s to become its Official Sleep Fitness Partner. The active Barry’s community can now level up their health and wellness, not only through fitness, but also through Eight Sleep’s advanced sleep technology. This partnership brings both communities greater access and education to the latest technologies and fitness regimes to elevate their health. With another main focus on R&D, Eight Sleep recently launched SleepOS, the world’s first operating system for sleep optimization that includes a new suite of cutting-edge features: Smart Temp Autopilot and Sleep and Health Insights. SleepOS acts as the brains of Eight Sleep and uses data to personalize and adjust the Pod towards each users’ unique sleep fitness goals. These features receive software updates regularly, continuously improving the experience of Eight Sleep products.
About Eight Sleep
Eight Sleep is the world's first sleep fitness company with a mission to fuel human potential through optimal sleep. Founded in 2014, Eight Sleep leverages thermoregulation, data, and technology to restore individuals to their peak energy levels every morning. Eight Sleep was named one of Fast Company's "Most Innovative Companies of 2018" and recognized two years in a row by TIME's Best Inventions of the Year. To learn more, visit eightsleep.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211117005295/en/
Contact information
Jack Taylor PR
Nadine Hachicho
nadine@jacktaylorpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Receives Marketing Clearance for Lumipulse ® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease17.5.2025 09:58:00 EEST | Press release
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an estimated 7.2 million Americans, a number projected to rise to nearly 14 million by 2060.1 It is a leading cause of disability and death. AD develops over many years, long before symptoms are evident, but the lack of accessible, minimally invasive diagnostics results in many patients remaining undiagnosed until the disease is well advanced, when few effective interventions remain. The Lumipulse G pT
IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes17.5.2025 00:17:00 EEST | Press release
IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050
Origins Launches in the U.S. Amazon Premium Beauty Store16.5.2025 16:00:00 EEST | Press release
Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516435958/en/ This launch marks a strategic step in Origins’ ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy and accessibility to even more consumers. Amazon customers will now be able to discover and purchase Or
The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow16.5.2025 13:47:00 EEST | Press release
Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 professionals from 157 nations took the opportunity to connect, initiate partnerships and launch new projects. The accompanying conferences and side events also attracted strong interest, drawing more than 2,600 participants. The message sent out by The smarter E Europe and its four exhibitions – Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe – was clear: We are the energy system. This press release features multimedia. View the full release here: https://www.businesswire.c
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes16.5.2025 13:30:00 EEST | Press release
IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025 Notes Series Tender Cap and the 2040 Notes Series Tender Cap (each as defined below) remain unchanged at $500,000,000 and $450,000,000, respectively. Details of tender offers IFF initially offered to purchase for cash: (i) up to $1,000,000,000 aggregate purchase price, excluding accrued and unpaid in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom